Replies to post #6957 on Navidea Biopharmaceuticals Inc (NAVB)

[AKAPAK]

Part I really like:

Sinotau is responsible for costs and conduct of clinical studies and regulatory applications to obtain Lymphoseek approval by the China Food and Drug Administration (CFDA). Upon approval, Sinotau will be responsible for all Lymphoseek sales, marketing, market access and medical affairs activities.

Nice way to entry a large market with nominal costs, and some cash along the way.